Allosteric modulation of β-cell M3muscarinic acetylcholine receptors greatly improves glucose homeostasis in lean and obese mice
- 26 August 2019
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 116 (37) , 18684-18690
Abstract
Significance: Type 2 diabetes (T2D) has emerged as a major threat to human health worldwide. In T2D, pancreatic β cells are unable to release sufficient amounts of insulin to maintain physiological blood glucose levels. Acetylcholine (ACh) stimulates insulin release from mouse and human pancreatic β cells by activating a cell surface receptor known as M3muscarinic ACh receptor (M3R). In the present study, we show that a drug that binds to an allosteric site on the M3R (a site distinct from the ACh-binding site) greatly enhances ACh-induced, M3R-mediated insulin release and improves glucose homeostasis in obese, glucose-intolerant mice. This proof-of-concept study strongly suggests that positive allosteric modulators of M3R function may prove beneficial for the treatment of T2D.Keywords
Funding Information
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK075021)
This publication has 34 references indexed in Scilit:
- Novel insights into the function of β-cell M3 muscarinic acetylcholine receptors: therapeutic implicationsTrends in Endocrinology & Metabolism, 2010
- Establishment of new clonal pancreatic β‐cell lines (MIN6‐K) useful for study of incretin/cyclic adenosine monophosphate signalingJournal of Diabetes Investigation, 2010
- RGS4 is a negative regulator of insulin release from pancreatic β-cells in vitro and in vivoProceedings of the National Academy of Sciences, 2010
- Chemical lead optimization of a pan Gq mAChR M1, M3, M5 positive allosteric modulator (PAM) lead. Part I: Development of the first highly selective M5 PAMBioorganic & Medicinal Chemistry Letters, 2009
- Loss of Lkb1 in Adult β Cells Increases β Cell Mass and Enhances Glucose Tolerance in MiceCell Metabolism, 2009
- Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetesNature Reviews Drug Discovery, 2009
- Discovery and Characterization of Novel Allosteric Potentiators of M1 Muscarinic Receptors Reveals Multiple Modes of ActivityMolecular Pharmacology, 2009
- Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disordersTrends in Pharmacological Sciences, 2009
- Muscarinic acetylcholine receptors: mutant mice provide new insights for drug developmentNature Reviews Drug Discovery, 2007
- Effects of muscarinic receptor type 3 knockout on mouse islet secretory responsesBiochemical and Biophysical Research Communications, 2004